
A total of 89.8 % of the Cuban population has already completed the vaccination program against COVID-19, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.
Read more Over 89% of the Cuban population completed anti-COVID-19 vaccination scheme
Cuban President Miguel Díaz-Canel highlighted the advances made by Cuban scientists against Alzheimer's disease after announcing the start of clinical trials of the drug NeuralCIM (NeuroEPO).

The Revolutionary Government will continue to promote the integration of all economic actors, which are the cornerstone for development and progress towards the welfare of the people, Cuban President Miguel Díaz-Canel said on Wednesday.
Photo: Alexey Mompeller.Page 332 of 498